Literature DB >> 34580976

A Cryptic Plant Terpene Cyclase Producing Unconventional 18- and 14-Membered Macrocyclic C25 and C20 Terpenoids with Immunosuppressive Activity.

Yue-Gui Chen1,2,3, De-Sen Li1,2,3, Yi Ling2, Yan-Chun Liu2,3, Zhi-Li Zuo2, Li-She Gan4, Shi-Hong Luo2, Juan Hua2, Ding-Yuan Chen2, Fan Xu4, Man Li2,3, Kai Guo1, Yan Liu1,2, Jonathan Gershenzon5, Sheng-Hong Li1,2.   

Abstract

A versatile terpene synthase (LcTPS2) producing unconventional macrocyclic terpenoids was characterized from Leucosceptrum canum. Engineered Escherichia coli and Nicotiana benthamiana expressing LcTPS2 produced six 18-/14-membered sesterterpenoids including five new ones and two 14-membered diterpenoids. These products represent the first macrocyclic sesterterpenoids from plants and the largest sesterterpenoid ring system identified to date. Two variants F516A and F516G producing approximately 3.3- and 2.5-fold, respectively, more sesterterpenoids than the wild-type enzyme were engineered. Both 18- and 14-membered ring sesterterpenoids displayed significant inhibitory activity on the IL-2 and IFN-γ production of T cells probably via inhibition of the MAPK pathway. The findings will contribute to the development of efficient biocatalysts to create bioactive macrocyclic sesterterpenoids, and also herald a new potential in the well-trodden territory of plant terpenoid biosynthesis.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  Leucosceptrum canum; enzyme engineering; immunosuppressive activity; macrocyclic terpenoids; sesterterpene synthase

Mesh:

Substances:

Year:  2021        PMID: 34580976     DOI: 10.1002/anie.202110842

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  1 in total

1.  The Biosynthesis and Transport of Ophiobolins in Aspergillus ustus 094102.

Authors:  Jingjing Yan; Jiamin Pang; Jianjia Liang; Wulin Yu; Xuequn Liao; Ayikaimaier Aobulikasimu; Xinrui Yi; Yapeng Yin; Zixin Deng; Kui Hong
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.